11:43 am GlaxoSmithKline confirmed approval in Canada for Incruse Ellipta (umeclidinium) as a treatment for COPD
View todays social media effects on GSK
View the latest stocks trending across Twitter. Click to view dashboard
See who GlaxoSmithKline is hiring next, click here to view
